Skip to main content

and
  1. No Access

    Article

    Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor

    Low severity of GVHD, substantial graft vs tumor (GVT) and slow development of protective immunity are well-documented features of cord blood transplants (CBT). We have evaluated the immune reconstitution of adul...

    T Martín-Donaire, M Rico, G Bautista, R Gonzalo-Daganzo in Bone Marrow Transplantation (2009)

  2. No Access

    Article

    Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor

    This open label clinical study provides updated evaluation of the strategy of single unit cord blood transplants (CBTs) with co-infusion of third-party donor (TPD) mobilized hematopoietic stem cells (MHSC). Fi...

    G Bautista, J R Cabrera, C Regidor, R Forés in Bone Marrow Transplantation (2009)

  3. No Access

    Article

    Chagas disease in a recipient of cord blood transplantation

    R Forés, I Sanjuán, F Portero, E Ruiz, C Regidor in Bone Marrow Transplantation (2007)

  4. No Access

    Article

    Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation

    An allogeneic transplantation of CD34+-selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical sibling donors was performed in 50 adult patients with acute myeloid leukemia in first complete remi...

    A Urbano-Ispizua, S Brunet, C Solano, JM Moraleda, M Rovira in Bone Marrow Transplantation (2001)

  5. No Access

    Article

    A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults

    In order to assess the potential clinical benefit of filgrastim (G-CSF) after peripheral blood stem cell (PBSC) autotransplantation a randomized study was begun in our center in July 1997: 62 patients were inv...

    E Ojeda, J Garcia-Bustos, MJ Aguado, R Arrieta, E Quevedo in Bone Marrow Transplantation (1999)

  6. No Access

    Article

    Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study

    We retrospectively compared the incidence and clinical characteristics of cGVHD in 37 allo-PBT recipients transplanted between July 1994 and October 1996 and 37 historical control allo-BMT recipients in a case...

    C Solano, C Martinez, S Brunet, JF Tomás, A Urbano-Ispizua in Bone Marrow Transplantation (1998)

  7. No Access

    Article

    Autotransplantation in chronic myeloid leukemia

    MJ Aguado, F Hernandez-Navarro, JL Bello, E Ojeda in Bone Marrow Transplantation (1998)

  8. No Access

    Article

    Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases

    A simplified cryopreservation method for bone marrow (BM) and peripheral blood progenitor cells (PBPC) was utilized in hematopoietic cell transplantation of 213 patients with hematological or solid neoplasms a...

    F Hernández-Navarro, E Ojeda, R Arrieta, P Ríos-Rull in Bone Marrow Transplantation (1998)

  9. No Access

    Article

    Haematopoietic transplantation in pulmonary alveolar proteinosis associated with chronic myelogenous leukaemia

    Pulmonary alveolar proteinosis (PAP) is a disease of unknown etiopathogenesis sometimes associated with malignant haematological disorders. The potential reversibility of the process in these cases seems to be...

    M Rguez-Luaces, A Lafuente, MP Martín, P Mateos, E Ojeda in Bone Marrow Transplantation (1997)